The collaboration between Insilico and HLFM aims to jointly develop a super-intelligence AI foundation model to decode the biological mechanisms of aging and enable predictive healthcare. Within this ...

Billions are pouring into anti-ageing biotech, but manipulating ageing has risks we are only beginning to understand.

BOSTON, MA — Aug 20, 2026 — Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company and organizer of the 13th Aging Research & Drug ...